IngateyGen

IngateyGen LLC is a biotechnology company focused on developing innovative, allergen-free peanut varieties to improve food safety and consumer health. Using advanced molecular techniques, including genomics, proteomics, and plant tissue culture, the company works to produce peanuts that are nutritionally and agronomically equivalent to conventional varieties while eliminating the proteins responsible for life-threatening allergic reactions. Founded by Dr. Hortense Dodo and Dr. Koffi Konan, the company evolved from academic research at Alabama A&M University into a commercial venture now based in Research Triangle Park, North Carolina. Their development strategy has progressed from initial RNA interference (RNAi) research to current efforts utilizing CRISPR genome editing to create non-GMO, allergen-free products.

The company's mission addresses the significant social and economic burden caused by peanut allergies, which affect millions of children and impact industries ranging from food manufacturing to aviation. IngateyGen has secured multiple research grants and contracts from the National Science Foundation (NSF) and the North Carolina Biotechnology Center to support its R&D platform and commercialization objectives. By partnering across the food value chain, IngateyGen aims to bring safer peanut options to market, mitigating the risks of anaphylaxis and reducing healthcare costs associated with allergic reactions. The company is supported by an expert team of scientists and strategic business advisors with extensive experience in food biotechnology, product development, and agricultural technology commercialization.